Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Hashimoto

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
In Vivo (Athens, Greece)|October 30, 2025
A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With <i>EGFR</i> Exon 19 Deletion Identified <i>via</i> Liquid Genomic ProfilingYohei Fukuda, Kosuke Hashimoto, Kyoichi Kaira, et al.
Thoracic Cancer|March 20, 2019
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumabOu Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, et al.
Chemotherapy|April 7, 2021
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine CarcinomaKen Naganuma, Hisao Imai, Ou Yamaguchi, et al.
Thoracic Cancer|February 19, 2020
Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non-small cell lung cancer harboring EGFR mutationOu Yamaguchi, Kyoichi Kaira, Tomonori Kawasaki, et al.
Cancer Research Communications|July 21, 2023
A Th1-like CD4<sup>+</sup> T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung CancerAkitoshi Yanagihara, Satoshi Yamasaki, Kosuke Hashimoto, et al.
Journal of Cancer Research and Clinical Oncology|January 22, 2025
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancerSatoshi Endo, Hisao Imai, Atsuto Mouri, et al.
Genome Research|February 15, 2019
Dynamics of cardiomyocyte transcriptome and chromatin landscape demarcates key events of heart developmentMichal Pawlak, Katarzyna Z Kedzierska, Maciej Migdal, et al.
Frontiers in Immunology|October 23, 2025
Eosinophils as predictive biomarkers in anti-programmed cell death 1 monotherapy for non-small cell lung cancerTakahiro Uchida, Kazuyuki Nakagome, Kosuke Hashimoto, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 InhibitorsKosuke Hashimoto, Soichiro Ide, Mayumi Arata, et al.
BMC Genomics|November 5, 2020
Analysis of splice variants of the human protein disulfide isomerase (P4HB) geneDaniela Kajihara, Chung-Chau Hon, Aimi Naim Abdullah, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
In Vivo (Athens, Greece)|October 30, 2025
A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With <i>EGFR</i> Exon 19 Deletion Identified <i>via</i> Liquid Genomic ProfilingYohei Fukuda, Kosuke Hashimoto, Kyoichi Kaira, et al.
Thoracic Cancer|March 20, 2019
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumabOu Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, et al.
Chemotherapy|April 7, 2021
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine CarcinomaKen Naganuma, Hisao Imai, Ou Yamaguchi, et al.
Thoracic Cancer|February 19, 2020
Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non-small cell lung cancer harboring EGFR mutationOu Yamaguchi, Kyoichi Kaira, Tomonori Kawasaki, et al.
Cancer Research Communications|July 21, 2023
A Th1-like CD4<sup>+</sup> T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung CancerAkitoshi Yanagihara, Satoshi Yamasaki, Kosuke Hashimoto, et al.
Journal of Cancer Research and Clinical Oncology|January 22, 2025
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancerSatoshi Endo, Hisao Imai, Atsuto Mouri, et al.
Genome Research|February 15, 2019
Dynamics of cardiomyocyte transcriptome and chromatin landscape demarcates key events of heart developmentMichal Pawlak, Katarzyna Z Kedzierska, Maciej Migdal, et al.
Frontiers in Immunology|October 23, 2025
Eosinophils as predictive biomarkers in anti-programmed cell death 1 monotherapy for non-small cell lung cancerTakahiro Uchida, Kazuyuki Nakagome, Kosuke Hashimoto, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 InhibitorsKosuke Hashimoto, Soichiro Ide, Mayumi Arata, et al.
BMC Genomics|November 5, 2020
Analysis of splice variants of the human protein disulfide isomerase (P4HB) geneDaniela Kajihara, Chung-Chau Hon, Aimi Naim Abdullah, et al.
Pageof 14